The Impact of Glycemic Control on Sodium-Glucose Co-Transporter 2 Inhibitor-Associated Genitourinary Infections

CONCLUSIONS AND RELEVANCE: Type 2 diabetes patients initiated on SGLT2is may experience an increased risk of GU infection, especially in those patients with an A1C of 9% or greater. Further research is necessary to validate and expand upon these findings.PMID:38321772 | DOI:10.1177/10600280241227973

Source: The Annals of Pharmacotherapy - February 7, 2024 Category: Drugs & Pharmacology Authors: Anthony Gerber Victoria Rupp Natalia Ryabenkova Nataliya Mikhelzon Source Type: research